The effects of long term Tranilast administration on bronchial hypersensitivity in asthmatics.
Tranilast is an oral antiallergic agent developed in Japan. This study investigated the effect of prolonged administration of Tranilast on the bronchial sensitivity of 18 asthmatic subjects. They were treated for either less than 3 months or more than 3 months continuously. Methacholine loading testing was used to assess bronchial reactivity, and the respiratory parameters were recorded on an Astograph. Patients treated for longer than 3 months showed a significant decrease in bronchial sensitivity (p less than 0.05). The anticholinergic and bronchodilatory properties of Tranilast were also investigated in 8 subjects. No significant anticholinergic or bronchodilatory effects were observed following a single oral dose of 100 mg of Tranilast.
Suzuki
H
H
Tanaka
K
K
Kaneshige
H
H
Nakagami
K
K
Noguchi
E
E
D000328:Adult; D001249:Asthma / Q000188:drug therapy* / Q000209:etiology; D001985:Bronchial Provocation Tests; D004341:Drug Evaluation; D006801:Humans; D006969:Hypersensitivity, Immediate / Q000150:complications / Q000188:drug therapy; D016210:Methacholine Chloride; D008688:Methacholine Compounds; D062367:ortho-Aminobenzoates / Q000008:administration & dosage / Q000627:therapeutic use*
D008688:Methacholine Compounds; D062367:ortho-Aminobenzoates; D016210:Methacholine Chloride; C012293:tranilast